Sapphire Bioscience Holding ApS: Financial statements 2020
CVR: 38599917
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Sapphire Bioscience Holding ApS (CVR 38599917) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -28,087 and a net result of DKK 25,059,219 compared with DKK 22,588,488 the year before. Equity in the 2020 report amounted to DKK 107,468,189. The solvency ratio was 93%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -28,087
- Profit/Loss
- DKK 25,059,219
- Equity
- DKK 107,468,189
- Total Assets
- DKK 115,573,677
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -28 t. | 25.1 mio. | 107.5 mio. | 1 |
| 2019 | - | -37 t. | 22.6 mio. | 101.3 mio. | 1 |
| 2018 | - | -62 t. | 40 mio. | 98.5 mio. | 1 |
Official annual report
How creditworthy is Sapphire Bioscience Holding ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Sapphire Bioscience Holding ApS has published its annual report for 2019. Gross profit came to DKK -37,258, and the net result was DKK 22,588,488.
About Sapphire Bioscience Holding ApS
Sapphire Bioscience Holding ApS is a Danish company of the type Anpartsselskab based in Ballerup, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Michel Krall Jürgens. The board consists of Harald Høegh (chair), Eirik Lauglo, Gustaf Peter Reinhold von Ehrenheim and Peter Max. The company is owned by TTJ Invest Holding ApS and Vind Industry AS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -112,000 and a net result of DKK 3,266,000 compared with DKK 38,793,000 the year before. Equity in the 2025 report amounted to DKK 148,277,000.